Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies-Reference-Cited by-同舟云学术

Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies

Published:2018-12 Issue:12 Volume:107 Page:3032-3046
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Patel Ashaben,Gupta Vineet,Hickey John,Nightlinger Nancy S.,Rogers Richard S.,Siska Christine,Joshi Sangeeta B.,Seaman Michael S.,Volkin David B.,Kerwin Bruce A.

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference81 articles.

1. A review on antibiotic resistance: alarm bells are ringing;Zaman;Cureus,2017

2. The process development challenge for a new vaccine;Buckland;Nat Med,2005

3. The fragility of the U.S. vaccine supply;Sloan;N Engl J Med,2004

4. The complexity and cost of vaccine manufacturing - an overview;Plotkin;Vaccine,2017

5. Antibodies for biodefense;Froude;MAbs,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives;Clinical Microbiology Reviews;2024-06-13

2. Analytical Performance Evaluation of Identity, Quality-Attribute Monitoring and new Peak Detection in a Platform Multi-Attribute Method Using Lys-C Digestion for Characterization and Quality Control of Therapeutic Monoclonal Antibodies;Journal of Pharmaceutical Sciences;2023-03

3. Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics;Journal of Pharmaceutical Sciences;2022-11

4. Stability Convergence in Antibody Coformulations;Molecular Pharmaceutics;2022-10-20

5. Stable High‐Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient;Advanced Therapeutics;2022-10-20